Qaelon Medical

What Qaelon Medical does

Qaelon Medical is a Strasbourg, France-based medical technology company developing the first automated, real-time digital platform for intraoperative surgical leak detection in minimally invasive surgery. The platform combines a proprietary constant-flow insufflation system with digital gas composition sensors and proprietary algorithms that detect minute changes in oxygen (O₂) and carbon dioxide (CO₂) concentrations, delivering objective, quantifiable leak test results in under 30 seconds. In more than 1,200 preclinical tests, the platform demonstrated 100% accuracy detecting 1mm leaks invisible to the naked eye, addressing a clinical problem (anastomotic surgical leaks affecting up to 19-30% of high-risk colorectal patients with mortality reaching 16.4-18% and treatment costs of $35,000-$121,000 per case) that has been served by an analog Air Leak Test unchanged for over a century.

The platform targets surgeons and hospital systems performing robotic, laparoscopic, and endoluminal gastrointestinal procedures, with secondary applications in thoracic and urologic surgery. Qaelon intends to monetize primarily through hardware sales of the dual-function insufflation and leak detection platform to hospital systems and surgical centers, with a potential future revenue stream from data, AI-powered clinical decision support, and EMR integration services built on its Objective Performance Indicator (OPI) data layer. Products are not yet FDA-cleared or commercially available in the U.S. or Europe, and the company has no disclosed customers, pricing, or distribution partners. The go-to-market is enterprise field sales to hospital systems, supported by clinical validation through industry competitions (2026 SAGES Shark Tank winner), scientific advisory boards, and strategic partnerships with NVIDIA, Caresyntax, FluidAI Medical, and Scialytics to position the platform as a foundational data source for surgical AI ecosystems.

Name

Qaelon Medical

Legal name

Qaelon Medical

Website

https://qaelonmedical.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Qaelon Medical is a Strasbourg-based medical technology company developing an automated, real-time digital platform that combines proprietary constant-flow insufflation with gas composition sensing to detect intraoperative surgical leaks during robotic, laparoscopic, and endoluminal minimally invasive procedures.

Ownership category

akta.pro rank

Product category

Surgical Leak Detection Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)

Keywords

• Surgical leak detection
• Intraoperative insufflation
• Minimally invasive surgery
• Robotic surgery platforms
• Digital surgical intelligence

Headquarters

HQ city

Strasbourg

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Surgical Device Platform Sales: Sale of the dual-function leak detection and insufflation platform hardware to hospital systems and surgical centers. The platform addresses 1 million+ procedures annually in the U.S. for leak detection and 38 million+ procedures globally requiring insufflation.
2. Data/Analytics Services: Potential future revenue from data analytics, AI-powered clinical decision support, and EMR integration services. The company positions its Objective Performance Indicator (OPI) data as a foundational layer for intelligent medtech and AI platforms.

Go-to-market motion2 records

Marketing channels5 records

Core offering

Qaelon Medical is developing a dual-function surgical platform that combines a proprietary constant-flow insufflation system with real-time digital intraoperative leak detection. The platform continuously samples gas composition (O₂ and CO₂) using advanced sensors and proprietary algorithms to detect sub-1mm leaks in under 30 seconds, replacing the century-old analog Air Leak Test with objective, EMR-exportable data across robotic, laparoscopic, and endoluminal procedures.

Product overview

Qaelon Medical offers a single unified platform for real-time digital intraoperative leak detection in minimally invasive surgery. The platform combines a proprietary constant-flow insufflation system with automated leak detection capabilities, supporting robotic, laparoscopic, and endoluminal surgery modalities. The system digitizes the century-old analog Air Leak Test into an objective, real-time physiologic signal that is quantifiable and exportable to EMR. In over 1,200 pre-clinical tests, the platform demonstrated 100% accuracy detecting 1mm leaks.

Differentiator

Problem solved

Functional benefit

Products and services

• Qaelon Surgical Leak Detection Platform First automated, real-time digital platform for intraoperative leak detection, built on a proprietary constant-flow insufflation system. Continuously samples gas composition (O₂ and CO₂) and detects leaks by identifying minute changes in real-time, delivering objective, quantifiable results in under 30 seconds with automated standardized leak-testing protocols and structured, exportable data for EMR integration and AI analytics. Intended for hospital systems and surgical centers performing robotic, laparoscopic, and endoluminal minimally invasive procedures.

Quantifiable outcome

• 100% accuracy detecting 1mm leaks in 1,200+ preclinical tests
• +3 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and supporting.

• ScialyticscoreTechnology or Integration · 3 June 2026Strategic, non-exclusive partnership to integrate Qaelon's real-time physiologic GI data into Scialytics' AI-driven surgical analytics platform targeting colorectal surgery. The collaboration combines Qaelon's Objective Performance Indicator (OPI) data with Scialytics' video-based surgical performance analytics. This represents Qaelon's first external signal of its broader strategy to position itself as a foundational data source for intelligent medtech platforms and AI ecosystems.
• FluidAI MedicalcoreStrategic or Co-development Partner · 1 May 2026Strategic collaboration to develop a unified surgical data ecosystem spanning from the operating room through patient recovery. Links Qaelon's intraoperative leak detection platform with FluidAI's FDA-cleared Origin™ monitoring device and Stream Care™ AI platform. Creates the first integrated framework spanning the full surgical journey from OR to recovery, addressing anastomotic leaks that affect up to 30% of some surgical populations.
• NVIDIAsupportingOthers · 22 March 2026Accepted into the NVIDIA Inception Program, a prestigious initiative designed to support startup companies pioneering advancements in AI and data science. Provides access to NVIDIA's cutting-edge technologies and global resources to accelerate AI-driven surgical leak detection development.
• CaresyntaxcoreStrategic or Co-development Partner · 26 April 2025Multi-phase partnership to build the first real-world evidence (RWE) platform for the measurement and clinical management of surgical leaks. Combines Qaelon's breakthrough leak detection technology with Caresyntax's market-leading expertise in surgical data and analytics to help establish a new standard of care for surgical leak detection.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Stryker: Stryker is a major surgical equipment manufacturer with insufflation, endoscopy, and digital surgery offerings that overlap with Qaelon's platform across minimally invasive surgery modalities.
• Ethicon (Johnson & Johnson): Ethicon is the market leader in surgical staplers and energy devices used in the same gastrointestinal procedures where leaks occur. Qaelon's CEO previously launched products at Ethicon, and Ethicon represents both a partnership opportunity and a competitive threat in leak-related workflows.
• Intuitive Surgical: Intuitive Surgical is the dominant robotic surgery platform (da Vinci). Qaelon's leak detection is designed to integrate into robotic workflows, making Intuitive the primary platform partner/incumbent whose installed base shapes Qaelon's addressable procedure volume.
• Medtronic: Medtronic offers a broad surgical portfolio including the Hugo robotic platform, Touch Surgery AI, and stapling devices relevant to anastomotic leak prevention. It is a broad incumbent across overlapping surgical device and AI/data categories.
• Karl Storz: Karl Storz is a leading endoscopy and insufflation equipment manufacturer with broad minimally invasive surgery presence, making it a relevant incumbent across Qaelon's robotic, laparoscopic, and endoluminal target segments.

Emerging players

• Moon Surgical: Moon Surgical is an emerging robotic-assisted surgery platform (Maestro) for laparoscopic procedures. It is comparable as a younger surgical robotics entrant whose adoption could be supported by Qaelon's leak detection and insufflation integration.
• Proximie: Proximie is a digital surgery platform enabling OR connectivity, telepresence, and data capture. It is comparable as an emerging platform building data infrastructure for the operating room, paralleling Qaelon's OPI positioning.
• CMR Surgical: CMR Surgical develops the Versius robotic surgery platform targeting laparoscopic procedures. As an emerging robotic platform competing with Intuitive, it is a relevant channel/integration partner for Qaelon's robotic leak detection capabilities.
• Activ Surgical: Activ Surgical is an emerging AI-driven surgical visualization and analytics company focused on intraoperative intelligence. It is comparable as an emerging platform building AI/data layers for the OR, intersecting with Qaelon's data strategy.

Direct peers

• Conmed (AirSeal): Conmed's AirSeal is a competing constant-pressure insufflation platform used in robotic and laparoscopic surgery. It is the most direct competitor to Qaelon's insufflation-plus-leak-detection offering and is explicitly cited as part of Qaelon CEO Liam Burns' prior commercial experience.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@QaelonMedical
• LinkedInlinkedin.com/company/qaelon-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qaelon Medical